1 – 10 of 10
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Noncanonical immunomodulatory activity of complement regulator C4BP(β-) limits the development of lupus nephritis
(
- Contribution to journal › Article
- 2014
-
Mark
Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients.
(
- Contribution to journal › Article
- 2013
-
Mark
Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study
(
- Contribution to journal › Article
- 2011
-
Mark
Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study
(
- Contribution to journal › Article
- 2009
-
Mark
Low toxicity regimens in renal transplantation: a country subset analysis of the Symphony study
(
- Contribution to journal › Article
-
Mark
Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant Recipients
(
- Contribution to journal › Article
-
Mark
Health-Related Quality of Life of Patients Receiving Low-toxicity Immunosuppressive Regimens:. A Substudy of the Symphony Study
(
- Contribution to journal › Article
-
Mark
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy
(
- Contribution to journal › Article
- 2008
-
Mark
Association of four DNA polymorphisms with acute rejection after kidney transplantation
(
- Contribution to journal › Article
- 2007
-
Mark
Reduced exposure to calcineurin inhibitors in renal transplantation.
(
- Contribution to journal › Article